Valneva SE (VALN) Cash from Operations Growth (3y) (2024 - 2026)
Valneva SE (VALN) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.46 Bn | 470.67 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 123.19 Bn | 115.94 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.44 Bn | 60.69 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - | - |
| 8 | Argenx Se | 57.08 Bn | 51.90 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.11 Bn | 38.11 Bn | - | - |
| 10 | Valneva SE | 837.53 Mn | 717.75 Mn | 5.38 Mn | 76.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.45% |
| Dec 31, 2025 | 22.42% |
| Sep 30, 2025 | 43.63% |
| Jun 30, 2025 | 66.89% |
| Mar 31, 2025 | 33.95% |
| Dec 31, 2024 | -41.82% |
| Sep 30, 2024 | 40.44% |
| Jun 30, 2024 | -44.29% |
| Mar 31, 2024 | -37.14% |